programs Taking full advantage of its unique setup of technologies and facilities, Bicoll has launched also its own drug development programs. Current ongoing activities are in the fields of: > Tuberculosis > Alzheimer disease To support these programs Bicoll is developing and building up its screening technology BIMATCH that is set up for rapid hit finding and high throughput.